Fuisz
This article was originally published in The Tan Sheet
Executive Summary
Contract with McNeil for development of Flash Dose acetaminophen product terminated, Fuisz says March 24; the company is "already in negotiation with a number of companies interested in acquiring marketing rights to Flash Dose acetaminophen." Fuisz expects to select a partner and launch the product in the U.S. by the end of the year. The company has re-negotiated three other early contracts to transfer manufacturing rights back to Fuisz. Remaining OTC product partners include SmithKline Beecham and Whitehall-Robins...